Literature DB >> 26629081

None detectable retrograde transport of Chinese botulinum toxin type A in mice by single intramuscular injection.

Bin Hong1, Lin-Lin Yao1, Xing-Yue Hu1.   

Abstract

Botulinum toxin type A (BoNT/A) can specifically cleave synaptosomal associated protein of 25 kDa (SNAP-25) into cleaved SNAP-25 (cl.SNAP-25), thus blocking the synaptic transmission in motor end plate and resulting in paralysis. It has been widely applied in clinical for treatment of various conditions characterized by muscle hyperactivity, such as dystonia and spasticity. BoNT/A is used locally, with little diffusion. Its paralyzing role is considered to be restricted to the nerve muscle junction, or close to the injection site. Recently, more and more studies, however, have suggested that BoNT/A also has central effects. In addition, some investigators have demonstrated that BoNT/A enters into central nervous system via retrograde transport after local intramuscular administration. The retrograde axonal transport of Chinese BoNT/A (CBoNT/A) was studied in this paper, which was rare in report. And the results showed that cl.SNAP-25 appeared not only at the injection site but also in contralateral muscle. Retrograde transport, however, was non-existent or too little to be detected in our study.

Entities:  

Keywords:  Botulinum toxin type A; cleaved SNAP-25; gastrocnemius; remote effect; retrograde transport

Year:  2015        PMID: 26629081      PMCID: PMC4658970     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

1.  Remote F-wave changes after local botulinum toxin application.

Authors:  K Wohlfarth; M Schubert; B Rothe; J Elek; R Dengler
Journal:  Clin Neurophysiol       Date:  2001-04       Impact factor: 3.708

Review 2.  Neurophysiological effects of botulinum toxin type A.

Authors:  G Abbruzzese; A Berardelli
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 3.  A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?

Authors:  Matteo Caleo; Flavia Antonucci; Laura Restani; Riccardo Mazzocchio
Journal:  J Neurochem       Date:  2009-02-11       Impact factor: 5.372

4.  Botulinum toxin's axonal transport from periphery to the spinal cord.

Authors:  Ivica Matak; Peter Riederer; Zdravko Lacković
Journal:  Neurochem Int       Date:  2012-05-08       Impact factor: 3.921

Review 5.  Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc.

Authors:  D Dressler; M Hallett
Journal:  Eur J Neurol       Date:  2006-02       Impact factor: 6.089

6.  Time course of distant effects of local injections of botulinum toxin.

Authors:  C G Garner; A Straube; T N Witt; T Gasser; W H Oertel
Journal:  Mov Disord       Date:  1993       Impact factor: 10.338

7.  Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.

Authors:  Lidija Bach-Rojecky; Melita Salković-Petrisić; Zdravko Lacković
Journal:  Eur J Pharmacol       Date:  2010-02-01       Impact factor: 4.432

8.  Genetic characteristics of toxigenic Clostridia and toxin gene evolution.

Authors:  Michel R Popoff; Philippe Bouvet
Journal:  Toxicon       Date:  2013-05-23       Impact factor: 3.033

9.  Distant effects of local injection of botulinum toxin.

Authors:  D J Lange; M F Brin; C L Warner; S Fahn; R E Lovelace
Journal:  Muscle Nerve       Date:  1987 Jul-Aug       Impact factor: 3.217

Review 10.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.